Symbol="RVMD"
AssetType="Common Stock"
Name="Revolution Medicines Inc"
Description="Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California."
CIK="1628171"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="700 SAGINAW DR, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3318029000"
EBITDA="-271241984"
PERatio="None"
PEGRatio="None"
BookValue="8.96"
DividendPerShare="0"
DividendYield="0"
EPS="-2.9"
RevenuePerShareTTM="0.406"
ProfitMargin="0"
OperatingMarginTTM="-7.91"
ReturnOnAssetsTTM="-0.196"
ReturnOnEquityTTM="-0.345"
RevenueTTM="34816000"
GrossProfitTTM="-217693000"
DilutedEPSTTM="-2.9"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.074"
AnalystTargetPrice="34.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="72.24"
PriceToBookRatio="3.162"
EVToRevenue="53.04"
EVToEBITDA="-6.63"
Beta="1.43"
num_52WeekHigh="33.19"
num_52WeekLow="17.03"
num_50DayMovingAverage="26.45"
num_200DayMovingAverage="24.18"
SharesOutstanding="106313000"
DividendDate="None"
ExDividendDate="None"
symbol="RVMD"
open="32.10"
high="32.42"
low="31.08"
price="31.21"
volume="1638286.00"
latest_trading_day="2023-08-04"
previous_close="31.89"
change="-0.68"
change_percent="-2.1323%"
aroon_positive_momentum_days="49"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="49"
Volume_recent_avg="1026761"
Change_recent_avg="0.09"
Delta_recent_avg="1.1"
Variance_recent_avg="0.55"
Change_ratio_recent_avg="0.27"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="49"
Aroon_momentum_negative="51"
image_negative_thumbnail_id_1="141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_negative_thumbnail_id_2="1091"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_neutral_thumbnail_id_1="572"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="647"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0061.jpeg"
image_positive_thumbnail_id_2="987"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
